Prostamax Research Guide

Full name: Prostamax (Prostate Peptide Bioregulator)

A short peptide bioregulator from the Khavinson family targeted at prostate tissue. Used in the bioregulator community to support prostate function and male urogenital health in short repeated courses.

How Prostamax Works

As a signal peptide, it is proposed to regulate gene expression in prostate tissue, supporting normal prostatic function, reducing inflammation-related dysfunction, and maintaining healthy urogenital tissue.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Prostate tissue support (proposed)
• Male urogenital health
• Anti-inflammatory tissue signaling (proposed)
• Short course-based protocol

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Prostate peptide bioregulators (2015) - Reported to support prostatic tissue function and urogenital health in regional research studies.

Related Sexual Health Compounds

• PT-141 (Bremelanotide) - Full Profile
• Kisspeptin-10 - Full Profile
• Melanotan II - Full Profile
• Oxytocin - Full Profile
• Tadalafil Peptide - Full Profile
• TriMix - Full Profile

View full Prostamax profile with 3D molecule viewer →